Tag Archives: diabetes treatment 2026

GLP-1 dose escalation is quickly becoming a central topic in diabetes care, especially as higher dosing strategies gain traction. But are we truly entering a high-dose era, or simply refining how we use these powerful agents? As clinicians face patients who plateau on standard regimens, the question becomes not just …

Interest in diabetes remission is growing in 2026, but is it realistic for everyone? As research evolves, clinicians are rethinking how and when to pursue remission as a treatment goal. While the idea of reversing type 2 diabetes is appealing, not every patient will benefit equally. This article explores the …